Previous 10 | Next 10 |
VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announce...
2023-06-08 14:25:49 ET Shares of Avita Medical (NASDAQ: RCEL) were up more than 16% early Thursday afternoon after the healthcare company got Food and Drug Administration (FDA) approval for a therapy to treat a skin disease. The stock is up more than 155% so far this year. A...
Shares of AVITA Medical, Inc. (NASDAQ: RCEL) traded at a new 52-week high today and are currently trading at $16.96. So far today, approximately 543.56k shares have been exchanged, as compared to an average 30-day volume of 209.9k shares. AVITA Medical Inc. operates as a commercial-stage rege...
2023-06-08 10:04:22 ET Gainers: Aclarion ( ACON ) +35% . Bone Biologics ( BBLG ) +17% . Atara Biotherapeutics ( ATRA ) +16% . Medigus ( MDGS ) +15% . AVITA Medical ( RCEL ) +13% . Losers: Panbela Therapeutics ( PBLA ) ...
VALENCIA, Calif. and MELBOURNE, Australia, June 07, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announce...
2023-05-12 12:42:14 ET Avita Medical ( NASDAQ: RCEL ) lost ~23% on Friday after the wound care company announced with Q1 2023 financials the resignation of its Chief Commercial Officer Erin Liberto from her position effective May 11. Ms. Liberto left her job to accept a ...
2023-05-12 10:03:10 ET Gainers: ARS Pharmaceuticals ( SPRY ) +77% . Dermata Therapeutics ( DRMA ) +63% . AirSculpt Technologies ( AIRS ) +27% . GlycoMimetics ( GLYC ) +14% . BioAtla ( BCAB ) +13% . Losers: Heron Thera...
2023-05-11 22:08:08 ET AVITA Medical, Inc. (RCEL) Q1 2023 Results Conference Call May 11, 2023 04:30 PM ET Company Participants Jessica Ekeberg - Investor Relations James Corbett - Chief Executive Officer Sean Ekins - Acting Chief Financial Officer Conferen...
2023-05-11 16:16:12 ET AVITA Medical press release ( NASDAQ: RCEL ): Q1 GAAP EPS of -$0.37 misses by $0.13 . Revenue of $10.55M (+39.9% Y/Y) beats by $0.25M . For further details see: AVITA Medical GAAP EPS of -$0.37 misses by $0.13, revenue of $10.55M be...
VALENCIA, Calif. and MELBOURNE, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “ Company ”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies f...
News, Short Squeeze, Breakout and More Instantly...
VALENCIA, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its second quarter 2024 financia...
VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M. Still Burn Center at Doctors Hosp...
2024-06-02 14:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...